No otrdienas, 9. novembra, ir b\u016btiski papla\u0161in\u0101ts to iedz\u012bvot\u0101ju loks, kuri var sa\u0146emt balstvakc\u012bnu pret Covid-19. No \u0161odienas \u0161\u012b iesp\u0113ja ir nodro\u0161in\u0101ta ar\u012b:<\/p>\n
L\u0113mums par iedz\u012bvot\u0101ju grupu papla\u0161in\u0101\u0161anu pie\u0146emts saska\u0146\u0101 ar Imuniz\u0101cijas valsts padomes rekomend\u0101cij\u0101m.<\/p>\n
<\/p>\n
\u201cNeraugoties uz jaunu iedz\u012bvot\u0101ju grupu atv\u0113r\u0161anu balstvakcin\u0101cijai pret Covid-19, procesa svar\u012bg\u0101k\u0101 priorit\u0101te ir senioru vecum\u0101 no 60 gadiem pirmreiz\u0113j\u0101 vakcin\u0101cija, k\u0101 ar\u012b papildu devu vakcin\u0101cija im\u016bnsupres\u0113t\u0101m person\u0101m. Svar\u012bga ir ar\u012b pirmreiz\u0113j\u0101 vakcin\u0101cija visiem iedz\u012bvot\u0101jiem, k\u0101 ar\u012b balstvakcin\u0101cija senioriem no 65 gadiem un SAC klientiem. Lai nodro\u0161in\u0101tu prim\u0101ro vakcin\u0101ciju, \u012bpa\u0161i riska grup\u0101s, vakcin\u0101cijas pakalpojumu sniedz\u0113ji ir aicin\u0101ti nodro\u0161in\u0101t riska grupu prioritiz\u0113\u0161anu taj\u0101s teritorij\u0101s un \u0123imenes \u0101rstu praks\u0113s, kur ir zema riska grupu vakcin\u0101cijas aptvere,\u201d akcent\u0113 NVD Vakcin\u0101cijas projekta noda\u013cas vad\u012bt\u0101ja Eva Juh\u0146\u0113vi\u010da.<\/p>\n
<\/p>\n
Balstvakcin\u0101cija pret Covid \u2013 19 <\/strong>nav<\/u><\/strong> nepiecie\u0161ama <\/strong>(iz\u0146emot cilv\u0113kus ar b\u016btiski nov\u0101jin\u0101tu im\u016bno sist\u0113mu) tiem, kuriem pirms, p\u0113c vai starp ab\u0101m vakc\u012bnas dev\u0101m bijis pozit\u012bvs SARS CoV-2 PCR tests un tiem, kuriem pirms vai p\u0113c vakcin\u0101cijas ar Janssen <\/em>vakc\u012bnu\u00a0 bijis pozit\u012bvs SARS CoV-2 PCR tests. Izv\u0113rt\u0113jot riskus un ieguvumus, cilv\u0113kiem, kas jaun\u0101ki par 30 gadiem bez nopietn\u0101m blakusslim\u012bb\u0101m balstvakcin\u0101cija vis\u0101 popul\u0101cij\u0101 neb\u016btu rekomend\u0113jama.<\/p>\n <\/p>\n Pieteik\u0161an\u0101s<\/strong> balstvakcin\u0101cijai<\/strong><\/p>\n Priorit\u0101ri iedz\u012bvot\u0101ji aicin\u0101ti pieteikties port\u0101l\u0101 Manavakcina.lv vai pa t\u0101lruni 8989 vai izmantot dz\u012bv\u0101s rindas iesp\u0113jas vakcin\u0101cijas centros, vakcin\u0101cijas punktos tirdzniec\u012bbas centros un pa\u0161vald\u012bbu telp\u0101s, izbraukuma un mobil\u0101s vakcin\u0101cijas puntkos. Balstvakcin\u0101ciju ir iesp\u0113jams sa\u0146emt ar\u012b vakcin\u0101cijas kabinetos \u0101rstiec\u012bbas iest\u0101d\u0113s un pie \u0123imenes \u0101rstiem.<\/p>\n <\/p>\n Vakc\u012bnu veidi<\/strong><\/p>\n Balstvakcin\u0101cija veicama ne \u0101tr\u0101k k\u0101 6 m\u0113ne\u0161us p\u0113c otr\u0101s devas sa\u0146em\u0161anas (p\u0113c Spikevax vakc\u012bnas balstvakcin\u0101cija ieteicama laika period\u0101 6-8 m\u0113ne\u0161us p\u0113c otr\u0101s devas sa\u0146em\u0161anas). Balstvakcin\u0101cijai tiek rekomend\u0113tas Spikevax vai Comirnaty vakc\u012bnas, ir pie\u013caujama ar\u012b Vaxzevria k\u0101 tre\u0161\u0101 deva p\u0113c pilna vakcin\u0101cijas kursa ar Vaxzevria vakc\u012bnu. Savuk\u0101rt, balstvakcin\u0101cija p\u0113c vienas Janssen <\/em>devas rekomend\u0113 veikt 8 ned\u0113\u013cas p\u0113c potes sa\u0146em\u0161anas.<\/p>\n Jau izsniegtie sertifik\u0101ti turpin\u0101s darboties. <\/strong>Digit\u0101laj\u0101 sertifik\u0101t\u0101 par\u0101d\u012bsies atz\u012bme par balstvakcin\u0101cijas veik\u0161anas datumu un vakc\u012bnas nosaukumu.<\/p>\n \u0122imenes \u0101rstu un \u0101rstniec\u012bbas iest\u0101\u017eu kontaktinform\u0101cija un adreses atrodama: https:\/\/www.vmnvd.gov.lv\/lv\/vakcinacija-iedzivotajiem<\/a><\/p>\n Balstvakcin\u0101cijas programmas m\u0113r\u0137is<\/strong> ir nov\u0113rst hospitaliz\u0101ciju, smagu saslim\u0161anu un n\u0101vi taj\u0101s sabiedr\u012bbas grup\u0101s, kur uz pier\u0101d\u012bjumiem balst\u012bti ir zin\u0101ms, ka prim\u0101r\u0101 imuniz\u0101cija var\u0113tu vairs nenodro\u0161in\u0101t optim\u0101lu im\u016bno aizsardz\u012bbu (im\u016bnsupres\u0113ti pacienti, iedz\u012bvot\u0101ji vecum\u0101 virs 65 gadiem, soci\u0101lo un apr\u016bpes centru pieaugu\u0161ie past\u0101v\u012bgie iedz\u012bvot\u0101ji, pacienti noteikt\u0101 vecum\u0101 ar hronisk\u0101m augsta riska blakussaslim\u0161an\u0101m).<\/p>\n Jau zi\u0146ots, ka Ministru kabinets \u0161.g. 7. septembr\u012b, l\u0113ma, ka ar\u012b Latvij\u0101, l\u012bdz\u012bgi k\u0101 citviet Eirop\u0101 un pasaul\u0113 tiks s\u0101kta tre\u0161o vakc\u012bnu devu pret Covid-19 administr\u0113\u0161ana. K\u0101 pirmie prim\u0101r\u0101s vakcin\u0101cijas kurs\u0101 papildu vakc\u012bnu devas pret Covid-19 s\u0101ka sa\u0146emt iedz\u012bvot\u0101ji ar b\u016btiski nov\u0101jin\u0101tu im\u016bno sist\u0113mu, kuriem prim\u0101r\u0101 vakcin\u0101cijas kurs\u0101 nav izveidojusies pietiekama aizsardz\u012bba. Balstvakcin\u0101cija pret Covid \u2013 19 tiek pied\u0101v\u0101ta ar\u012b ieddz\u012bvot\u0101jiem, kas vec\u0101ki par 65 gadiem, <\/em>person\u0101m, kas ir vec\u0101kas par 50 gadiem ar hroniskaj\u0101m slim\u012bb\u0101m, pieaugu\u0161ajiem soci\u0101l\u0101s apr\u016bpes centru un pansion\u0101tu klientiem, ar\u012b vesel\u012bbas apr\u016bpes sist\u0113m\u0101 var tikt pie\u013cauta papildu devas sa\u0146em\u0161ana\u00a0tiem darbiniekiem, kam ir ilgsto\u0161a saskarsme gan ar Covid-19 pacientiem, gan pret Covid-19 nevakcin\u0113tiem pacientiem\u00a0un l\u012bdz ar to augsts profesion\u0101lais un lok\u0101la uzliesmojuma risks, k\u0101 ar\u012b im\u016bnsupres\u0113t\u0101m person\u0101m. Uz \u0161o br\u012bdi veikti gandr\u012bz 20000 balstvakcin\u0101cijas fakti.<\/p>\n Ir svar\u012bgi turpin\u0101t iedz\u012bvot\u0101ju vakcin\u0101ciju, lai p\u0113c iesp\u0113jas \u0101tr\u0101k pasarg\u0101tu ikviena vesel\u012bbu, \u012bpa\u0161i svar\u012bgi vakcin\u0113ties iedz\u012bvot\u0101jiem, kuri ir riska grup\u0101s \u2013 seniori, cilv\u0113ki ar hronisk\u0101m saslim\u0161an\u0101m. \u0160obr\u012bd Latvij\u0101 vismaz vienu vakc\u012bnas devu sa\u0146\u0113mu\u0161i 63.3 % iedz\u012bvot\u0101ju, no tiem vakcin\u0101cijas kursu pabeigu\u0161i 56%, bet vecum\u0101 12+ pirmo poti sa\u0146\u0113mis 72%, bet vakcin\u0101cijas kursu pabeigu\u0161i 64%. Bezmakas vakcin\u0101cija pieejama ikvienam iedz\u012bvot\u0101jam no 12 gadu vecuma un tai var pieteikties pa t\u0101lruni 8989, vietn\u0113 manavakcina.lv vai pie sava \u0123imenes \u0101rsta.<\/p>\n \u00a0<\/strong><\/p>\n *<\/strong> S\u012bk\u0101k par hroniskaj\u0101m slim\u012bb\u0101m: https:\/\/www.spkc.gov.lv\/lv\/hroniski-slimo-pacientu-vakcinacija<\/a><\/strong><\/p>\n ** Saska\u0146\u0101 ar Sabiedr\u012bbas vakcin\u0101cijas darba grup\u0101 lemto: personas, kas atrodas ilgsto\u0161\u0101 savstarp\u0113j\u0101 saskarsm\u0113, non\u0101k fizisk\u0101 kontakt\u0101 vai ilgsto\u0161i atrodas tuv\u0101k par diviem metriem (atra\u0161an\u0101s sl\u0113gt\u0101 vid\u0113 (piem\u0113ram, klas\u0113, san\u0101ksmju z\u0101le, slimn\u012bcas uzgaid\u0101m\u0101 telp\u0101, kabinet\u0101 u.tml.) vai brauk\u0161ana ilg\u0101k par 15 min\u016bt\u0113m vien\u0101 transportl\u012bdzekl\u012b);<\/p>\n – ja personai ir paaugstin\u0101tas iesp\u0113jas infic\u0113ties, atrodoties tie\u0161\u0101 saskarsm\u0113 un kontakt\u0113joties ar person\u0101m, kuru vesel\u012bbas st\u0101voklis nav zin\u0101ms.<\/p>\n","protected":false},"excerpt":{"rendered":" No otrdienas, 9. novembra, ir b\u016btiski papla\u0161in\u0101ts to iedz\u012bvot\u0101ju loks, kuri var sa\u0146emt balstvakc\u012bnu pret Covid-19. No \u0161odienas \u0161\u012b iesp\u0113ja ir nodro\u0161in\u0101ta ar\u012b: visiem iedz\u012bvot\u0101jiem no 50 gadiem, iedz\u012bvot\u0101jiem vecum\u0101 no 18 gadiem, ja ir hroniskas slim\u012bbas* vai str\u0101d\u0101 augsta…
Las\u012bt visu<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[9],"tags":[],"class_list":["post-28988","post","type-post","status-publish","format-standard","hentry","category-noderiga-informacija"],"_links":{"self":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/28988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/comments?post=28988"}],"version-history":[{"count":0,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/posts\/28988\/revisions"}],"wp:attachment":[{"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/media?parent=28988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/categories?post=28988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aluksne.lv\/index.php\/wp-json\/wp\/v2\/tags?post=28988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}